ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Massachusetts » Child Adolescent Psychiatry

Top Child Adolescent Psychiatry Prescribers in Massachusetts

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOHN JULIAN MD

Child Adolescent Psychiatry

9,562

$714K

408
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 19%

$75
Average prescription price

Avg: $101

STEPHEN IKEDA M.D.

Child Adolescent Psychiatry

5,535

$790K

212
14 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 19%

$143
Average prescription price

Avg: $101

PAUL REDSTONE M.D.

Child Adolescent Psychiatry

3,344

$305K

296
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 19%

$91
Average prescription price

Avg: $101

SANGITA MALLICK M.D.

Child Adolescent Psychiatry

3,159

$344K

192
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

18%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 19%

$109
Average prescription price

Avg: $101

SHANNON SCARRY MD

Child Adolescent Psychiatry

2,955

$404K

118
0 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 19%

$137
Average prescription price

Avg: $101

MICHAEL ENDE M.D.

Child Adolescent Psychiatry

2,709

$200K

144
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 19%

$74
Average prescription price

Avg: $101

THEODOR ENE M.D.

Child Adolescent Psychiatry

2,515

$165K

165
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 19%

$66
Average prescription price

Avg: $101

MARTIN HART M.D.

Child Adolescent Psychiatry

2,472

$284K

165
22 are 65+

23%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 19%

$115
Average prescription price

Avg: $101

MARINA RADISIC-BASOVIC MD

Child Adolescent Psychiatry

2,415

$187K

157
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 19%

$78
Average prescription price

Avg: $101

PETER SALTZMAN M.D.

Child Adolescent Psychiatry

2,365

$206K

110
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 19%

$87
Average prescription price

Avg: $101

LOUIS VELAZQUEZ MD

Child Adolescent Psychiatry

1,999

$250K

146
11 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 19%

$125
Average prescription price

Avg: $101

OURANIA MADIAS MD

Child Adolescent Psychiatry

1,817

$138K

210
61 are 65+

18%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 19%

$76
Average prescription price

Avg: $101

JAMES MC GUIRE MD

Child Adolescent Psychiatry

1,725

$222K

65
14 are 65+

31%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 19%

$128
Average prescription price

Avg: $101

JOSEPH BIEDERMAN MD

Child Adolescent Psychiatry

1,569

$262K

46
0 are 65+

30%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 19%

$167
Average prescription price

Avg: $101

NICHOLAS MOFFA M.D.

Child Adolescent Psychiatry

1,298

$84.1K

98
39 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 19%

$65
Average prescription price

Avg: $101

JOSEPH SHRAND MD

Child Adolescent Psychiatry

1,276

$221K

35
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 19%

$173
Average prescription price

Avg: $101

MATTHEW FRIEDMAN MD

Child Adolescent Psychiatry

1,114

$79.8K

137
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 19%

$72
Average prescription price

Avg: $101

MICHAEL MARCUS MD

Child Adolescent Psychiatry

1,039

$130K

88
31 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 19%

$125
Average prescription price

Avg: $101

SAROJ JOSHI M.D

Child Adolescent Psychiatry

842

$74.9K

52
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 19%

$89
Average prescription price

Avg: $101

MICHAEL LARSON DO

Child Adolescent Psychiatry

828

$118K

43
16 are 65+

44%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 19%

$142
Average prescription price

Avg: $101

IRWIN BENNETT MD

Child Adolescent Psychiatry

805

$103K

47
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 19%

$128
Average prescription price

Avg: $101

VICTORIA WOLFSON M.D.

Child Adolescent Psychiatry

788

$73.3K

28
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 19%

$93
Average prescription price

Avg: $101

GAURAV CHAWLA M.D.

Child Adolescent Psychiatry

742

$70K

42
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 19%

$94
Average prescription price

Avg: $101

SHAHRZAD YAMINI MD

Child Adolescent Psychiatry

713

$54.3K

50
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 19%

$76
Average prescription price

Avg: $101

JOHN ZEBRUN M.D.

Child Adolescent Psychiatry

691

$47.4K

34
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 19%

$69
Average prescription price

Avg: $101

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank